Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Cancer Reports (Hoboken, N.J.)|October 11, 2024
Irene Attucci, Sofia Pilerci, Maria Messeri, et al.
Journal of Clinical Medicine|April 30, 2021
Venetoclax-Based Regimens for Relapsed/Refractory Acute Myeloid Leukemia in a Real-Life Setting: A Retrospective Single-Center ExperienceMatteo Piccini, Sofia Pilerci, Marta Merlini, et al.
Cancers|August 14, 2025
Combined Minimal Residual Disease Evaluation in Bone Marrow and Apheresis Samples in Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplantation Improves Outcome PredictionIrene Attucci, Benedetta Peruzzi, Chiara Nozzoli, et al.
Frontiers in Oncology|May 14, 2023
Carfilzomib, lenalidomide, and dexamethasone in relapsed refractory multiple myeloma: a prospective real-life experience of the Regional Tuscan Myeloma NetworkElisabetta Antonioli, Sofia Pilerci, Irene Attucci, et al.
British Journal of Haematology|July 30, 2022
Neutralizing monoclonal antibodies in haematological patients paucisymptomatic for COVID-19: The GIMEMA EMATO-0321 studyVincenzo Marasco, Alfonso Piciocchi, Anna Candoni, et al.
Haematologica|June 22, 2023
Effect of age and treatment on predictive value of measurable residual disease: implications for clinical management of adult patients with acute myeloid leukemiaFrancesco Mannelli, Matteo Piccini, Sara Bencini, et al.
Haematologica|April 30, 2025
Lenalidomide maintenance after bortezomib, thalidomide and dexamethasone (VTD) induction and autologous stem cell transplantation: an Italian real-life study of 602 patientsGregorio Barilà, Angela Grassi, Concetta Conticello, et al.
Blood Advances|October 13, 2021
A prognostic model for patients with lymphoma and COVID-19: a multicentre cohort studyCarlo Visco, Luigi Marcheselli, Roberto Mina, et al.
Pageof 1